VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 60.04% | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 60.04% | -- | -- | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 60.04% | -- | -- | -100.00% |
| SG&A Expenses | -23.58% | -34.72% | -3.27% | -21.11% | -22.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.05% | -40.97% | -18.25% | -26.52% | -20.32% |
| Operating Income | 29.46% | 46.42% | 16.44% | 32.23% | 17.66% |
| Income Before Tax | 77.87% | 40.48% | 10.21% | 24.19% | 10.19% |
| Income Tax Expenses | 37.25% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 81.07% | 40.48% | 10.21% | 24.19% | 16.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.07% | 40.48% | 10.21% | 24.19% | 16.75% |
| EBIT | 29.46% | 46.42% | 16.44% | 32.23% | 17.66% |
| EBITDA | 29.50% | 46.46% | 16.44% | 32.21% | 17.58% |
| EPS Basic | 80.85% | 43.10% | 13.64% | 26.79% | 18.97% |
| Normalized Basic EPS | 21.88% | 41.67% | 12.20% | 25.71% | 11.11% |
| EPS Diluted | 80.85% | 43.10% | 13.64% | 26.79% | 18.97% |
| Normalized Diluted EPS | 21.88% | 41.67% | 12.20% | 25.71% | 11.11% |
| Average Basic Shares Outstanding | 4.16% | 6.22% | 4.40% | 3.46% | 2.86% |
| Average Diluted Shares Outstanding | 4.16% | 6.22% | 4.40% | 3.46% | 2.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |